Shah Pritesh

The estimated Net Worth of Shah Pritesh is at least $7 Million dollars dollars as of 05/26/2022. Shah Pritesh is the Chief Commercial Officer of NovoCure Ltd. Shah Pritesh owns over 83,187 shares of NovoCure Ltd stock worth over $7 Million dollars .

Shah Pritesh mailing address: C/O NOVOCURE INC. 20 VALLEY STREAM PARKWAY, SUITE 300 MALVERN PA 19355

Insider Roles

Name Transaction Date Position
NovoCure Ltd 2018-07-01 officer: Chief Commercial Officer
EMBED
SAVE

Shah Pritesh trading transactions

Ticker Company Current Price Insider Name Insider Position Date Buy/Sell Insider Trading Shares Shares Change Price Cost Final Share Price Change Since Insider Trade (%) Filing Date Dividend Yield % PE Ratio Market Cap ($M)
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2022-03-09 Sell
3,669
-4.22%
$71.19
$261,196
83,187
11.69%
2022-03-11
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2022-03-08 Sell
7,775
-8.67%
$69.73
$542,151
81,908
14.03%
2022-03-09
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2022-03-04 Sell
5,543
-5.82%
$72.54
$402,089
89,683
9.61%
2022-03-07
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2021-08-04 Sell
2,063
-2.71%
$148.71
$306,789
74,169
-46.53%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2021-08-03 Sell
1,654
-2.12%
$149.43
$247,157
76,232
-46.79%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2021-06-10 Sell
23,540
-23.24%
$215
$5,061,100
77,732
-63.02%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2021-05-05 Sell
1,290
-1.26%
$199.67
$257,574
101,272
-60.18%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2021-03-09 Sell
6,151
-5.73%
$130.97
$805,596
101,272
-39.29%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2021-03-05 Sell
4,550
-4.06%
$131.53
$598,462
107,423
-39.55%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2021-03-04 Sell
4,832
-4.70%
$143.50
$693,392
97,986
-44.59%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2020-09-09 Sell
28,321
-28.67%
$85.41
$2,418,900
70,465
-6.91%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2020-09-02 Sell
4,200
-4.08%
$85.01
$357,042
98,786
-6.47%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2020-08-04 Sell
3,717
-3.55%
$76.63
$284,834
101,018
3.76%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2020-05-05 Sell
1,149
-1.13%
$62.20
$71,467.80
100,693
27.83%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2020-05-04 Sell
1,184
-1.15%
$60.08
$71,134.70
101,842
32.34%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2020-03-06 Sell
6,151
-5.76%
$66.76
$410,641
100,693
19.10%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2020-03-02 Sell
1,485
-2.15%
$72.97
$108,360
67,721
8.96%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2020-02-28 Sell
1,601
-2.26%
$72.22
$115,624
69,206
10.09%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2020-02-26 Sell
12,999
-16.10%
$80.08
$1,040,960
67,721
-0.71%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2019-08-02 Sell
1,813
-2.30%
$85.23
$154,522
76,976
-6.71%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2019-08-01 Sell
7,020
-8.18%
$83
$582,660
78,789
-4.20%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2019-07-26 Sell
12,500
-13.97%
$77.94
$974,250
76,976
2.01%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2019-07-18 Sell
7,500
-8.88%
$70
$525,000
76,976
13.59%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2019-06-27 Sell
11,175
-14.66%
$60.30
$673,852
65,037
31.86%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2019-06-19 Sell
12,500
-14.09%
$60
$750,000
76,212
32.52%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2019-06-10 Sell
1,130
-1.46%
$55.05
$62,206.50
76,212
44.43%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2019-05-02 Sell
1,204
-1.53%
$43.80
$52,735.20
77,342
81.53%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2019-03-01 Sell
40,586
-61.66%
$55.63
$2,257,800
25,239
42.93%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2019-02-28 Sell
1,558
-5.81%
$53.68
$83,633.40
25,239
48.12%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2019-01-16 Sell
25,000
-59.40%
$45
$1,125,000
17,087
76.69%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2019-01-11 Sell
26,251
-60.57%
$42
$1,102,540
17,087
89.31%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2019-01-09 Sell
8,988
-34.47%
$40
$359,520
17,087
98.78%
-
0
At Loss
8,309.89
NVCR
NovoCure Ltd
$79.51
Shah Pritesh
Chief Commercial Officer
2018-12-12 Sell
38,781
-69.42%
$36
$1,396,120
17,087
120.86%
-
0
At Loss
8,309.89
Total 33
  • 1

Shah Pritesh personal network

Name Position Linked company